Pluri entered strategic collaborations across Asia, Europe and the United States ('U.S.”) to transform food and agriculture production via its subsidiaries’ advanced cell expansion ...
Nucleome Therapeutics ('Nucleome' or 'the Company'), an immunology company tackling the root causes of disease through a revolutionary new approach to solving human genetics, is delighted that its ...
PROPOSED LISTING OF CELL C HOLDINGS LIMITED ON THE MAIN BOARD OF THE JSE LIMITED AND ABRIDGED PRE-LISTING STATEMENT THE ABRIDGED PRE-LISTING STATEMENT DOES NOT CONSTITUTE AN OFFER TO ANY PERSON IN ANY ...
1don MSN
Halting pancreatic cancer spread: Protein-degrading drugs show promise in preclinical models
Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade ...
At its November 6 meeting, the Bulloch County BOE continued to discuss potential budget cuts. The consensus was to delay any ...
CELL C HOLDINGS LIMITED ANNOUNCES ITS INTENTION TO LIST ON THE MAIN BOARD OF THE JSE • Cell C Limited (‘Cell C’) is a South African telecommunications and technology company, with a recognisable brand ...
The new NEXO features a comprehensively reengineered powertrain, with a hydrogen fuel cell system that delivers 110 kW of ...
Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today recaps its pivotal ...
Ginkgo reaffirmed its full-year 2025 revenue guidance of $167 million to $187 million, with Cell Engineering revenue expected to be $117 million to $137 million and Biosecurity revenue expected to be ...
Discover the top 10 sprung flooring suppliers delivering sustainable, high-resilience studio floors across the UK. Featuring ...
One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results